When was the first personalized cancer vaccine administered in Russia?

The first personalized cancer vaccine, Neooncovac, was administered on April 1.

What type of cancer was the first patient diagnosed with?

The first patient received the vaccine for skin melanoma.

What is the goal of the Neooncovac personalized cancer vaccine?

The Neooncovac vaccine aims to 'teach' the immune system to identify and eliminate specific cancer cells, personalizing treatment.

Home / Health / Russia Trials Personalized Cancer Vaccine

Russia Trials Personalized Cancer Vaccine

1 Apr

•

Summary

First personalized cancer vaccine administered on April 1.
Patient received Neooncovac vaccine for skin melanoma.
Vaccine "teaches" immune system to fight cancer cells.

Russia Trials Personalized Cancer Vaccine

On April 1, Russia marked a significant milestone in cancer treatment by administering the first Neooncovac personalized anti-cancer vaccine. This groundbreaking procedure took place at the National Medical Research Center for Radiology in Moscow.

The inaugural patient was a 60-year-old individual from the Kursk Region diagnosed with skin melanoma. This Neooncovac vaccine represents a new frontier in oncology, focusing on mRNA technology tailored to each patient.

According to Andrey Kaprin, the director general of the Radiology Center, this approach signifies a fundamental shift. It aims to personalize cancer treatment by instructing the patient's own immune system to precisely target and destroy harmful cells.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.